Cannabis Suisse Corp Stock Performance
| CSUI Stock | USD 0.02 0 5.56% |
Cannabis Suisse holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -7.22, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Cannabis Suisse are expected to decrease by larger amounts. On the other hand, during market turmoil, Cannabis Suisse is expected to outperform it. Use Cannabis Suisse treynor ratio and the relationship between the semi variance and relative strength index , to analyze future returns on Cannabis Suisse.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Suisse Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Cannabis Suisse demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Cannabis |
Cannabis Suisse Relative Risk vs. Return Landscape
If you would invest 2.50 in Cannabis Suisse Corp on September 3, 2024 and sell it today you would lose (0.60) from holding Cannabis Suisse Corp or give up 24.0% of portfolio value over 90 days. Cannabis Suisse Corp is currently generating 8.6735% in daily expected returns and assumes 66.8818% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Cannabis, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cannabis Suisse Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cannabis Suisse's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Cannabis Suisse Corp, and traders can use it to determine the average amount a Cannabis Suisse's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1297
| Best Portfolio | Best Equity | CSUI | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 66.88 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Cannabis Suisse is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cannabis Suisse by adding it to a well-diversified portfolio.
Cannabis Suisse Fundamentals Growth
Cannabis Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Cannabis Suisse, and Cannabis Suisse fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cannabis Pink Sheet performance.
| Return On Asset | -3.08 | |||
| Operating Margin | (25.44) % | |||
| Current Valuation | 3.37 M | |||
| Shares Outstanding | 40.65 M | |||
| Price To Sales | 732.00 X | |||
| Revenue | 7.77 K | |||
| EBITDA | (122.31 K) | |||
| Cash And Equivalents | 5 | |||
| Total Debt | 102.73 K | |||
| Debt To Equity | 273.30 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (32.09 K) | |||
| Earnings Per Share | (0.01) X | |||
About Cannabis Suisse Performance
By evaluating Cannabis Suisse's fundamental ratios, stakeholders can gain valuable insights into Cannabis Suisse's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cannabis Suisse has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cannabis Suisse has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. Cannabis Suisse Corp. was incorporated in 2016 and is based in Bell Gardens, California. CANNABIS SUISSE is traded on OTC Exchange in the United States.Things to note about Cannabis Suisse Corp performance evaluation
Checking the ongoing alerts about Cannabis Suisse for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Cannabis Suisse Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cannabis Suisse Corp is way too risky over 90 days horizon | |
| Cannabis Suisse Corp has some characteristics of a very speculative penny stock | |
| Cannabis Suisse Corp appears to be risky and price may revert if volatility continues | |
| Cannabis Suisse Corp has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Cannabis Suisse Corp currently holds 102.73 K in liabilities with Debt to Equity (D/E) ratio of 273.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Cannabis Suisse Corp has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cannabis Suisse until it has trouble settling it off, either with new capital or with free cash flow. So, Cannabis Suisse's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cannabis Suisse Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cannabis to invest in growth at high rates of return. When we think about Cannabis Suisse's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 7.77 K. Net Loss for the year was (187.89 K) with profit before overhead, payroll, taxes, and interest of 6.04 K. | |
| Cannabis Suisse Corp currently holds about 5 in cash with (32.09 K) of positive cash flow from operations. | |
| Roughly 31.0% of Cannabis Suisse shares are held by company insiders |
- Analyzing Cannabis Suisse's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cannabis Suisse's stock is overvalued or undervalued compared to its peers.
- Examining Cannabis Suisse's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cannabis Suisse's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cannabis Suisse's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cannabis Suisse's pink sheet. These opinions can provide insight into Cannabis Suisse's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cannabis Pink Sheet analysis
When running Cannabis Suisse's price analysis, check to measure Cannabis Suisse's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabis Suisse is operating at the current time. Most of Cannabis Suisse's value examination focuses on studying past and present price action to predict the probability of Cannabis Suisse's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabis Suisse's price. Additionally, you may evaluate how the addition of Cannabis Suisse to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |